Abstract: A peripheral access module transports voice and data between the common control equipment and the peripheral equipment of a telephone switch. The peripheral access module determines the protocol for transporting the voice and data, and determines the type of medium to effect the transporting. The peripheral access module operatively connects to the peripheral equipment and adaptively reside on a card of the common control equipment.

Abstract: A modular digital telephone system and method featuring a universal telephony shelf adaptable for incremental expansion of legacy telephone switches and as a building block in the construction of new telephony switches. The shelf includes identification and connectors for shelf pairing, and is adapted to receive redundant power supplies, plural line cards, and either a peripheral shelf interface unit or a switch array card which provides both a local shelf interface and three interface units for connection to the peripheral interface units of other shelves. System wide fault displays are provided.

Abstract: An apparatus and method for a telephone system includes a telephony switch comprising a timing and switch array card for effecting all switching and timing functions of the switch, a plurality of telephony line cards operatively connected to the timing and switch array card, and at least one power supply operatively connected to both the timing and switch array card and the plurality of line cards wherein said timing and switching functions comprise tone and conference functions, line card slot and alarm board interface functions, PCM switching functions, signal scanning and signal packet transfer buffer support functions, host computer interface functions, and clock and synchronization functions.

Abstract: A modular digital telephone system and method featuring a universal telephony shelf adaptable for incremental expansion of legacy telephone switches and as a building block in the construction of new telephony switches. The shelf includes identification and connectors for shelf pairing, and is adapted to receive redundant power supplies, plural line cards, and either a peripheral shelf interface unit or a switch array card which provides both a local shelf interface and three interface units for connection to the peripheral interface units of other shelves. System wide fault displays are provided.

Abstract: A modular digital telephone system and method featuring a universal telephony shelf adaptable for incremental expansion of legacy telephone switches and as a building block in the construction of new telephony switches. The shelf includes identification and connectors for shelf pairing, and is adapted to receive redundant power supplies, plural line cards, and either a peripheral shelf interface unit or a switch array card which provides both a local shelf interface and three interface units for connection to the peripheral interface units of other shelves. System wide fault displays are provided.

Abstract: A method of treating a disease of condition administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said disease or condition and a form of hyaluronic acid characterized in that the composition is immediately available to transport the drug percutaneously into the epidermis of the skin or exposed tissue to the site of trauma or pathology of the disease or condition to be treated.

Abstract: Pharmaceutical compositions from which effective non-toxic (to the patient) dosage amounts may be taken and applied to the skin and/or exposed tissue of a human, each effective dosage amount comprising pharmaceutical excipients suitable for topical application, an effective non-toxic dosage amount of a drug to treat and to assist to resolve a disease and/or condition of the skin and/or exposed tissue or a human and an effective non-toxic dosage amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub-units or hyaluronic acid sufficient to transport (to facilitate or cause the transport of) the drug, to a site in the skin including epidermis or exposed tissue or a disease or condition for percutaneous transport into the skin and/or exposed tissue to accumulate and remain there for a prolonged period of time and which is systemic independent acting.

Abstract: The invention relates to a method of rapidly transporting a drug to the epidermis and accumulating and maintaining the drug therein for a prolonged period of time comprising administration of a therapeutically efective non-toxic amount of the drug with an effective amount of hyaluronic acid.

Abstract: A method of treating a disease or condition comprising administering topically to the skin or exposed tissue of a human, a dosage amount of a pharmaceutical composition, said dosage comprising a therapeutically effective amount of a drug to treat said disease or condition and a form of hyaluronic acid characterized in that the composition is immediately available to transport the drug percutaneously into the epidermis of the skin or exposed tissue to the site of trauma or pathology of the disease or condition to be treated.

Abstract: Topically applied transdermally quick penetrating (best targeting the epidermis and subsequently remaining there for a prolonged period of time) systemic independent acting, combinations and formulations which employ, combine, or incorporate a therapeutically effective non-toxic (to the patient) amount of a drug which inhibits prostaglandin synthesis together with an amount of hyaluronic acid and/or salts thereof (for example the sodium salt) and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub units of hyaluronic acid to treat a disease and condition of the skin and exposed tissue for example, basal cell carcinoma, the precancerous, often recurrent, actinic keratoses lesions, fungal lesions, "liver" spots and like lesions (found for the most part in the epidermis), squamous cell tumours, metastatic cancer of the breast to the skin, primary and metastatic melanoma in the skin, genital warts cervical cancer, and HPV (Human Papilloma Virus) including HPV of the cervix, psoriasis (

Abstract: A method of accumulating a drug and a form of hyaluronic acid in the skin and/or exposed tissue of a human includes topically administering a therapeutically effective dosage amount of a formulation which comprises at least 5 mg/cm.sup.2 of the form of hyaluronic acid and a therapeutically effective amount of the drug.

Abstract: In a wireless communication system in which a base station communicates with plural mobile stations using frames of digital data, each frame having a control slot and plural voice (or data) slots, the present invention divides at least some of the slots into two portions and receives communications from one of the mobile stations during a first portion of a voice slot and communicates with the same mobile station during the second portion of the same slot.

Abstract: Pharmaceutical compositions from which effective non-toxic (to the patient) dosage amounts may be taken and applied to the skin and/or exposed tissue of a human, each effective dosage amount comprising pharmaceutical excipients suitable for topical application, an effective non-toxic dosage amount of a drug to treat and to assist to resolve a disease and/or condition of the skin and/or exposed tissue of a human and an effective non-toxic dosage amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub-units of hyaluronic acid sufficient to transport (to facilitate or cause the transport of) the drug, to a site in the skin including epidermis or exposed tissue of a disease or condition for percutaneous transport into the skin and/or exposed tissue to accumulate and remain there for a prolonged period of time and which is systemic independent acting.

Abstract: In a wireless communication system in which plural base stations communicate with plural mobile stations using a control slot and plural voice (or data) slots, the present invention dynamically allocates which of a predetermined set of frequencies are used by a given base station at a given time. The base stations monitor the predetermined set of frequencies to determine which frequencies are being used within which slots within the range of radio reception of the base station. Currently unused frequency/slot combinations are assigned by a base station to service the next request for a voice slot.

Abstract: In a wireless communication system in which a base station communicates with plural mobile stations using a control channel and plural voice (or data) channels, the present invention uses the control channel as a voice channel whenever the other voice channels are in use and a request is received from a mobile station for another voice channel. The base station's use of the control channel varies as the control channel switches from a control channel to a voice channel and back to a control channel again.

Abstract: The invention relates to a method of controlling the unloading of a drug from the skin or exposed tissue of a human into the lymphatic system comprising transporting an effective dosage amount of the drug into the skin or exposed tissue by an effective non-toxic amount of a form of hyaluronic acid.

Abstract: A system and method for readily varying the configuration of a telephone system and the functions/features available to the users of wireless telephone instruments on the system. The telephone instruments may include a display which can be configured by interaction with a base station to vary the interpretation given to inputs received from the user. Features available to the user of a particular telephone instrument may be specifically adapted to the user and may be readily modified as the user changes, as the user's authorization changes, and/or as the telephone system's capabilities are changed.

Abstract: Pharmaceutical compositions from which effective non-toxic (to the patient) dosage amounts may be taken and applied to the skin and/or exposed tissue of a human, each effective dosage amount comprising pharmaceutical excipients suitable for topical application, an effective non-toxic dosage amount of a drug to treat and to assist to resolve a disease and/or condition of the skin and/or exposed tissue of a human and an effective non-toxic dosage amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub-units of hyaluronic acid sufficient to transport (to facilitate or cause the transport of) the drug, to a site in the skin including epidermis or exposed tissue of a disease or condition for percutaneous transport into the skin and/or exposed tissue to accumulate and remain there for a prolonged period of time and which is systemic independent acting.

Abstract: A wireless PBX system utilizes base stations dispersed throughout an area to be served with wireless telephone service. The base stations utilize multiple antennae to reduce problems associated with fading and multipath. In the present invention, the antennae of a base station or similar apparatus are rotatable, at least in pairs, so that the base station may be hung vertically, horizontally, or at some other angle to the horizon and the antennae may be readily oriented to a position which provides for preferred propagation characteristics for the antennae for the local area in which the base station is mounted.

Abstract: Topically applied transdermally quick penetrating compositions containing a drug and hyaluronic acid and/or salts thereof and methods of treating diseases and conditions employing said compositions.